Vitamin B3, NR, NMN and NAD+: how they connect

NAD+ in one paragraph

Nicotinamide adenine dinucleotide, or NAD+, is used by hundreds of enzymes. It shuttles electrons in the reactions that turn food into usable energy, and it is consumed by enzymes involved in DNA repair and cell signaling, such as PARPs and sirtuins. Because it is used up constantly, your body recycles it and also builds it from dietary sources. Animal research shows NAD+ falls with age, which is why it attracts so much interest.

The family of precursors

Think of these molecules as different entry points into the same factory. Each is converted, through one or more steps, into NAD+. They differ in how many steps they need, how they behave at high doses and how they are sold.

• Nicotinic acid (niacin): the classic form of vitamin B3. At higher doses it causes flushing, and prescription-strength versions have been used to treat cholesterol.
• Nicotinamide (also called niacinamide): another B3 form. It does not cause flushing and is common in multivitamins.
• Nicotinamide riboside (NR): a B3 form that enters the salvage pathway a step closer to NAD+. It is sold as a supplement.
• Nicotinamide mononucleotide (NMN): one step away from NAD+. It is sold as a supplement, and its legal status changed in 2025.
• Tryptophan: an amino acid in protein foods that the body can convert to NAD+, though inefficiently.

How much B3 you actually need

The NIH Office of Dietary Supplements sets the adult recommended intake at 16 mg niacin equivalents a day for men and 14 mg for women. Poultry, beef, fish, nuts, legumes and fortified grains all supply it, and true deficiency (pellagra) is very rare in the U.S.

The upper intake limit for supplemental niacin is 35 mg a day for adults, set mainly to avoid flushing. Doctors sometimes prescribe far more for specific reasons, but large trials of high-dose nicotinic acid added to statins did not reduce heart attacks or strokes and were linked to side effects, so it is not a casual supplement at those doses.

What human studies show for NR and NMN

The precursor studies are reassuring on safety and consistent on one point: they raise NAD+ and related molecules in blood. A 2018 randomized crossover trial in adults aged 55 to 79 found that 1,000 mg a day of NR raised NAD+ in blood cells by about 60% and was well tolerated. A 2023 review in The Journals of Gerontology concluded that NR and NMN are safe and raise NAD+ levels, but that evidence of improved physiological function is unclear.

A separate 2023 review in Science Advances was more blunt, finding few clinically relevant effects of oral NR in humans and no consistent changes in insulin sensitivity, metabolic rate or muscle function. Studies are generally small and short, and they mostly measure blood levels rather than how people feel.

How each one is regulated

Niacin is an established vitamin, and prescription forms are FDA-approved drugs for lipid management. NR and NMN are sold as dietary supplements, which do not need FDA approval before sale; manufacturers are responsible for safety and labeling.

NMN had a rocky path. FDA said in 2022 that it could not be marketed as a supplement because it had been studied as a drug, then reversed that position in letters dated September 29, 2025, confirming that NMN is not excluded from the supplement definition. Companies still have to meet new dietary ingredient notification requirements.

Injectable NAD+ is different again. It is prepared by compounding pharmacies, is not FDA-approved, and has not been reviewed by FDA for safety, effectiveness or quality.

Where an NAD+ injection fits

An injection delivers NAD+ itself rather than a precursor. That bypasses digestion, but the body breaks NAD+ down quickly, and there are no trials showing injections produce better outcomes than oral precursors. For most people, the sensible order is to check for common causes of low energy first, then decide whether a time-limited trial of any NAD+ approach is worth it.

Before you buy anything, it helps to ask three questions. What exactly is in the product, and has a third party tested it? What do you expect to change, and how will you know? And has anything more common, such as low iron, thyroid disease or poor sleep, been ruled out?

If you and your clinician decide to try it, HealifyMD's compounded NAD+ Injection starts at $199/month with no membership fee. Labs are priced separately, and your price is confirmed at the eligibility review.